159 related articles for article (PubMed ID: 7692237)
21. Interaction of epitope-related and -unrelated peptides with anti-p24 (HIV-1) monoclonal antibody CB4-1 and its Fab fragment.
Welfle K; Misselwitz R; Höhne W; Welfle H
J Mol Recognit; 2003; 16(1):54-62. PubMed ID: 12557239
[TBL] [Abstract][Full Text] [Related]
22. Anti-peptide reagent identifies a primary-structure-dependent, cross-reactive idiotype expressed on heavy and light chains from a murine monoclonal anti-CD4.
Attanasio R; Kanda P; Stunz GW; Buck DW; Kennedy RC
Mol Immunol; 1993 Jan; 30(1):9-17. PubMed ID: 8417378
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of a human monoclonal antibody that interacts with a sulfated tyrosine-containing epitope of the GPIb receptor and inhibits platelet functions.
Hagay Y; Lahav J; Levanon A; Varon D; Brill A; Panet A
Mol Immunol; 2006 Feb; 43(5):443-53. PubMed ID: 16337487
[TBL] [Abstract][Full Text] [Related]
24. Fabs specific for 8-oxoguanine: control of DNA binding.
Bespalov IA; Bond JP; Purmal AA; Wallace SS; Melamede RJ
J Mol Biol; 1999 Nov; 293(5):1085-95. PubMed ID: 10547287
[TBL] [Abstract][Full Text] [Related]
25. Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro.
Barbas CF; Björling E; Chiodi F; Dunlop N; Cababa D; Jones TM; Zebedee SL; Persson MA; Nara PL; Norrby E
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9339-43. PubMed ID: 1384050
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and immunological characterization of a 134-mer synthetic peptide corresponding to the N-terminal half of the HIV-1 nucleoprotein, p24.
Chong P; Sia C; Tam E; Kandil A; Klein M
Int J Pept Protein Res; 1993 Jan; 41(1):21-7. PubMed ID: 7679666
[TBL] [Abstract][Full Text] [Related]
27. Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10.
Cardoso RM; Brunel FM; Ferguson S; Zwick M; Burton DR; Dawson PE; Wilson IA
J Mol Biol; 2007 Feb; 365(5):1533-44. PubMed ID: 17125793
[TBL] [Abstract][Full Text] [Related]
28. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
[TBL] [Abstract][Full Text] [Related]
29. Mimicry of human IgE epitopes by anti-idiotypic antibodies.
Vogel M; Miescher S; Kuhn S; Zürcher AW; Stadler MB; Ruf C; Effenberger F; Kricek F; Stadler BM
J Mol Biol; 2000 May; 298(5):729-35. PubMed ID: 10801344
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a new intrabody directed against the N-terminal region of human p53.
Cohen PA; Mani JC; Lane DP
Oncogene; 1998 Nov; 17(19):2445-56. PubMed ID: 9824155
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
[TBL] [Abstract][Full Text] [Related]
32. Analysis of antibody-antigen and antibody-anti-(idiotypic antibody) cross-reactivity using synthetic peptide probes.
McInerney TL; Brown LE; Sutton VR; Jackson DC
Mol Immunol; 1994 Mar; 31(4):289-99. PubMed ID: 7511212
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a mouse/human chimeric monoclonal antibody (C beta 1) to a principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
Matsushita S; Maeda H; Kimachi K; Eda Y; Maeda Y; Murakami T; Tokiyoshi S; Takatsuki K
AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1107-15. PubMed ID: 1380258
[TBL] [Abstract][Full Text] [Related]
34. The crystal structures of complexes formed between lysozyme and antibody fragments.
Bentley GA
EXS; 1996; 75():301-19. PubMed ID: 8765306
[TBL] [Abstract][Full Text] [Related]
35. Recombinant thyroid peroxidase-specific autoantibodies. II. Role of individual heavy and light chains in determining epitope recognition.
Costante G; Portolano S; Nishikawa T; Jaume JC; Chazenbalk GD; Rapoport B; McLachlan SM
Endocrinology; 1994 Jul; 135(1):25-30. PubMed ID: 7516865
[TBL] [Abstract][Full Text] [Related]
36. Mapping the B cell superantigen binding site for HIV-1 gp120 on a V(H)3 Ig.
Neshat MN; Goodglick L; Lim K; Braun J
Int Immunol; 2000 Mar; 12(3):305-12. PubMed ID: 10700465
[TBL] [Abstract][Full Text] [Related]
37. A highly conserved interspecies V(H) in the human genome.
Vogel M; Tschopp C; Bobrzynski T; Fux M; Stadler MB; Miescher SM; Stadler BM
J Mol Biol; 2004 Aug; 341(2):477-89. PubMed ID: 15276838
[TBL] [Abstract][Full Text] [Related]
38. Chemical modification of recombinant HIV-1 capsid protein p24 leads to the release of a hidden epitope prior to changes of the overall folding of the protein.
Ehrhard B; Misselwitz R; Welfle K; Hausdorf G; Glaser RW; Schneider-Mergener J; Welfle H
Biochemistry; 1996 Jul; 35(28):9097-105. PubMed ID: 8703914
[TBL] [Abstract][Full Text] [Related]
39. Interaction between the antigen and antibody is controlled by the constant domains: normal mode dynamics of the HEL-HyHEL-10 complex.
Adachi M; Kurihara Y; Nojima H; Takeda-Shitaka M; Kamiya K; Umeyama H
Protein Sci; 2003 Oct; 12(10):2125-31. PubMed ID: 14500870
[TBL] [Abstract][Full Text] [Related]
40. Fine mapping of the antigen-antibody interaction of scFv215, a recombinant antibody inhibiting RNA polymerase II from Drosophila melanogaster.
Liu Z; Song D; Kramer A; Martin AC; Dandekar T; Schneider-Mergener J; Bautz EK; Dübel S
J Mol Recognit; 1999; 12(2):103-11. PubMed ID: 10398401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
